Document is current
Any future updates will be listed below
-
Authors
van der Velde, Nikki
Poleij, Anne
Lenzen, Mattie J.
Budde, Ricardo P. J.
Brabander, Tessa
Miedema, Jelle R.
Schinkel, Arend F. L.
Michels, Michelle
Hirsch, Alexander https://orcid.org/0000-0002-3315-2006
- License Information
-
More Information
Article History
Accepted: 6 December 2024
First Online: 9 January 2025
Conflict of interest
: R.P. J. Budde reports speaker fees and honoraria for advisory board participation from Bayer. Institutional support was paid to the Erasmus Medical Centre in Rotterdam by Siemens and HeartFlow. J.R. Miedema has received consultancy and speaker fees from Boehringer-Ingelheim and speaker fees from Roche and Novartis. M. Michels has received a research grant, consultancy fees, and speaker fees from Bristol Meyer Squibb, consultancy fees from Cytokinetics, and speaker fee from Sanofi-Genzyme. She also serves as an editor of the Netherlands Heart Journal. A. Hirsch has received a research grant and consultancy fees from GE Healthcare and speaker fees from GE Healthcare, Bristol Meyer Squibb and Bayer. He also serves as an editor of the Netherlands Heart Journal, is a member of the medical advisory board of Medis Medical Imaging Systems and was the MRI corelab supervisor of Cardialysis BV until 2022. N. van der Velde, A. Poleij, M.J. Lenzen, T. Brabander and A.F.L. Schinkel declare that they have no competing interests.
